Type 2 Diabetes Medications: SGLT2 Inhibitors

Size: px
Start display at page:

Download "Type 2 Diabetes Medications: SGLT2 Inhibitors"

Transcription

1 Type 2 Diabetes Medications: SGLT2 Inhibitors SGLT2 inhibitors are a class of type 2 diabetes medications used along with diet and exercise to lower blood glucose How are they taken? SGLT2 inhibitors is short for sodium glucose co-transporter 2 inhibitors Taken orally (by mouth) How do they work? Help to stop glucose from being taken in by the kidneys: the kidneys help to remove glucose from the blood. In people with type 2 diabetes, the kidneys can hold on to glucose, which can cause blood glucose levels to increase What are the benefits? Modest weight loss There is a low risk of hypoglycemia (blood glucose that is too low) with SGLT2 inhibitors. Hypoglycemia can cause tiredness/weakness, nervousness, shakiness, confusion, fast heartbeat, problems with vision, and fainting or seizures What are the side effects? Your healthcare provider will partner with you to create a type 2 diabetes management plan that is personalized to your needs and preferences. Take any medications as directed by your healthcare provider and tell your healthcare provider if you have any side effects. Most common: Yeast infections in men and women Urinary tract infection Increased need to urinate Stuffy or runny nose and sore throat There are two SGLT2 inhibitors approved by the U.S. Food and Drug Administration (FDA): Canagliflozin (INVOKANA ) Dapagliflozin (FARXIGA ) Also possible: Low blood pressure (hypotension) Kidney problems (renal impairment) Hypoglycemia if taken with a sulfonylurea or insulin High amounts of potassium in the blood (hyperkalemia; canagliflozin) Increased LDL-C (the bad cholesterol) Bladder cancer (dapagliflozin) Allergic reactions SGLT2 inhibitors are FDA approved for use along with diet and exercise to lower blood glucose in adults with type 2 diabetes. These medications are not FDA approved for weight loss. For informational purposes only. Consult full manufacturer s prescribing information and medication guide for medication s uses, actions, and side by the U.S. FDA..org NATIONAL DIABETES EDUCATION INITIATIVE FOR MORE INFORMATION: T A LK W I T H Y O UR H E A LT H C A RE PR OV I D ER REFERENCES: FARXIGA [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; Hasan FM, Alsahli M, Gerich JE. Diabetes Res Clin Pract. 2014;104(3): INVOKANA [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; Kim Y, Babu AR. Diabetes Metab Syndr Obes. 2012;5: MedlinePlus. Hypoglycemia. Available at: July 2014 Sponsored by KnowledgePoint360 Group, LLC, Lyndhurst, NJ. Copyright 2013 KnowledgePoint360 Group, LLC. All rights reserved. This content was created by KnowledgePoint360 Group, LLC, and was not Thisassociated content was created by KnowledgePoint360 Group, LLC, and was not associated with funding via an educational grant or a promotional/commercial interest. with funding via an educational grant or a promotional/commercial interest.

2 Type 2 Diabetes Medications: DPP-4 Inhibitors DPP-4 inhibitors are a class of type 2 diabetes medications used along with diet and exercise to lower blood glucose How are they taken? DPP-4 inhibitors is short for dipeptidyl peptidase-4 inhibitors Taken orally (by mouth) How do they work? Help your pancreas to make more insulin: insulin helps to lower blood glucose Lower the amount of glucose made by your liver What are the benefits? DPP-4 inhibitors are weight neutral, meaning they do not cause weight gain There is a low risk of hypoglycemia (blood glucose that is too low) with DPP-4 inhibitors. Hypoglycemia can cause tiredness/weakness, nervousness, shakiness, confusion, fast heartbeat, problems with vision, and fainting or seizures What are the side effects? Your healthcare provider will partner with you to create a type 2 diabetes management plan that is personalized to your needs and preferences. Take any medications as directed by your healthcare provider and tell your healthcare provider if you have any side effects. Most common: Upper respiratory tract infection Stuffy or runny nose and sore throat Headache Upset stomach or diarrhea There are four DPP-4 inhibitors approved by the U.S. Food and Drug Administration (FDA): Alogliptin (NESINA) Linagliptin (TRADJENTA ) Saxagliptin (ONGLYZA ) Sitagliptin (JANUVIA ) Also possible: Inflammation of the pancreas (acute pancreatitis) Hypoglycemia if taken with a sulfonylurea or insulin Liver problems (alogliptin) Kidney problems (renal failure; sitagliptin) Allergic reactions DPP-4 inhibitors are FDA approved for use along with diet and exercise to lower blood glucose in adults with type 2 diabetes. These medications are not FDA approved for weight loss. For informational purposes only. Consult full manufacturer s prescribing information and medication guide for medication s uses, actions, and side by the U.S. FDA..org NATIONAL DIABETES EDUCATION INITIATIVE FOR MORE INFORMATION: T A LK W I T H Y O U R H E A LT H C A RE PR OV I D ER REFERENCES: Brunton S. Int J Clin Pract. 2014;68: Davidson JA. Mayo Clinic Proc. 2010;85(12 suppl):s27-s37. Inzucchi SE, et al. Diabetes Care. 2012;35(6): JANUVIA [package insert]. Whitehouse Station, NJ: Merck & Co, Inc.; MedlinePlus. Hypoglycemia. Available at: NESINA [package insert]. Deerfield, IL: Takeda Pharmaceuticals America, Inc.; ONGLYZA [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; TRADJENTA [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc.; June 2014 Sponsored by KnowledgePoint360 Group, LLC, Lyndhurst, NJ. Copyright 2013 KnowledgePoint360 Group, LLC. All rights reserved. This content was created by KnowledgePoint360 Group, LLC, and was not Thisassociated content was created by KnowledgePoint360 Group, LLC, and was not associated with funding via an educational grant or a promotional/commercial interest. with funding via an educational grant or a promotional/commercial interest.

3 Type 2 Diabetes Medications: GLP-1 Receptor Agonists GLP-1 receptor agonists are a class of type 2 diabetes medications used along with diet and exercise to lower blood glucose How are they given? Given as an injection: inserted into the fat under your skin GLP-1 receptor agonists is short for glucagon-like peptide-1 receptor agonists How do they work? Help your pancreas to make more insulin: insulin helps to lower blood glucose Lower the amount of glucose made by your liver Help to slow down the breakdown of your food: this slows down increases in blood glucose What are the benefits? Your healthcare provider will partner with you to create a type 2 diabetes management plan that is personalized to your needs and preferences. Take any medications as directed by your healthcare provider and tell your healthcare provider if you have any side effects. Modest weight loss May make you feel less hungry and more full There is a low risk of hypoglycemia (blood glucose that is too low) with GLP-1 receptor agonists. Hypoglycemia can cause tiredness/weakness, nervousness, shakiness, confusion, fast heartbeat, problems with vision, and fainting or seizures There are three GLP-1 receptor What are the side effects? agonists approved by the U.S. Most common: Food and Drug Administration Diarrhea (FDA): Nausea Reactions/itching at the injection site Exenatide (BYETTA ) Vomiting Exenatide extended release Headache (BYDUREON ) Indigestion Liraglutide (Victoza ) Constipation Also possible: Thyroid tumors, including cancer, were seen in rats and mice in studies during the medication testing process Inflammation of the pancreas (acute pancreatitis) Hypoglycemia if taken with a sulfonylurea or insulin Kidney problems (renal impairment) Allergic reactions GLP-1 receptor agonists are FDA approved for use along with diet and exercise to lower blood glucose in adults with type 2 diabetes. These medications are not FDA approved for weight loss. For informational purposes only. Consult full manufacturer s prescribing information and medication guide for medication s uses, actions, and side by the U.S. FDA..org NATIONAL DIABETES EDUCATION INITIATIVE FOR MORE INFORMATION: T A LK W I T H Y O U R H E A LT H C A RE PR OV I D ER REFERENCES: Brunton S. Int J Clin Pract. 2014;68: BYDUREON [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; BYETTA [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; Davidson JA. Mayo Clinic Proc. 2010;85(12 suppl):s27-s37. Inzucchi SE, et al. Diabetes Care. 2012;35(6): MedlinePlus. Hypoglycemia. Available at: Victoza [package insert]. Plainsboro, NJ: Novo Nordisk Inc.; June 2014 Sponsored by KnowledgePoint360 Group, LLC, Lyndhurst, NJ. Copyright 2013 KnowledgePoint360 Group, LLC. All rights reserved. This content was created by KnowledgePoint360 Group, LLC, and was not Thisassociated content was created by KnowledgePoint360 Group, LLC, and was not associated with funding via an educational grant or a promotional/commercial interest. with funding via an educational grant or a promotional/commercial interest.

4 Medications Used to Treat Type 2 Diabetes This handout shows the different medications that your healthcare provider may prescribe to treat your type 2 diabetes, and where and how these medications work in your body to lower blood glucose. Type 2 diabetes medications are taken orally (by mouth), by injection (inserted into the fat under your skin), or inhaled (breathed in). Oral Injectable Amylin mimetic (pramlintide) Alpha-glucosidase inhibitors (acarbose, miglitol) Helps to decrease the amount of glucose made by your liver. Help to slow down the breakdown of starches (such as bread and potatoes) and certain types of sugar (such as table sugar) from your food in your intestines: this slows down increases in blood glucose. Helps to slow down the breakdown of foods in your stomach and intestines: this slows down increases in blood glucose GLP-1 receptor agonists (albiglutide, dulaglutide, exenatide, liraglutide) Help your pancreas to make more insulin: insulin helps to lower blood glucose Biguanide (metformin) Helps to decrease the amount of glucose made by your liver Helps to improve the way that insulin works in your muscles: if your muscles are more sensitive to insulin, it is easier for insulin to bring glucose from your blood into your muscles where glucose can be used for energy Help to decrease the amount of glucose made by your liver Helps to slow down the breakdown of foods in your stomach and intestines: this slows down increases in blood glucose DPP-4 inhibitors (alogliptin, linagliptin, saxagliptin, sitagliptin) Fat Tissue Help your pancreas to make more insulin: insulin helps to lower blood glusoce Insulins (aspart, detemir, glargine, glulisine, human, lispro) Replace the insulin made naturally by your body in your pancreas Help to decrease the amount of glucose made by your liver Dopamine receptor agonist (bromocriptine mesylate) The mechanism by which dopamine receptor agonists improve blood sugar is unknown Help to decrease the amount of glucose made by your liver Muscle Liver Help to move glucose from the bloodstream into your muscles and fat where glucose is used for energy Kidneys Some insulin is inhaled See pg. 2 Meglitinides (nateglinide, repaglinide) Help your pancreas to make more insulin: insulin helps to lower blod glucose Stomach SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin) Help to stop glucose from being reabsorbed into your kidneys. The kidneys help to remove glucose from your blood. In people with type 2 diabetes, the kidneys can hold on to glucose which can cause blood glucose levels to increase Sulfonylureas (glimepiride, glipizide, gliburide) Helps your pancreas to make more insulin: insulin helps to lower blood glucose Pancreas Intestines Descriptions are provided for informational purposes only. Consult full manufacturer s prescribing information for drug s uses, actions, and side by the U.S. Food and Drug Administration (FDA) unless otherwise noted. Consult individual manufacturer s prescribing information for approved uses outside the United States. REFERENCES ADA. Other injectable medications. Available at: Thiazolidinediones (pioglitazone, rosiglitazone) Helps to decrease the amount of glucose made by your liver Help to improve the way that insulin works in your muscles and fat: if your muscles are more sensitive to insulin, it is easier for insulin to bring glucose from your blood into your muscles and fat where glucose can be used for energy FOR MOREhttp:// INFORMATION: T A LK W I T Hmedication/insulin/other-injectable-medications.html. Y O UR H E A LT H C A RE PR OV I D ER ADA. What are my options? Available at: Inzucchi SE, et al. Diabetes Care. 2012;35(6): Mayo Clinic. Diabetes treatment: medications for type 2 diabetes. Available at: Updated December 2014 For more information, talk to your healthcare provider This content was created by KnowledgePoint360 Group, LLC, and was not associated with funding via an educational grant or a promotional/commercial interest.

5 Medications Used to Treat Type 2 Diabetes Oral Injectable Alpha-glucosidase inhibitors (acarbose, miglitol) Available as Glyset (miglitol); PRECOSE (acarbose) Amylin mimetic (pramlintide) Available as SYMLIN (pramlintide) Biguanide (metformin) Available as Fortamet, GLUCOPHAGE, GLUCOPHAGE XR, Glumetza, Riomet (metformin) ACTOplus met, ACTOplus met XR (pioglitazone and metformin); Avandamet (rosiglitazone and metformin); GLUCOVANCE (gliburide and metformin); Janumet, Janumet XR (metformin and sitagliptin); Jentadueto (linagliptin and metformin); KAZANO (alogliptin and metformin); KOMBIGLYZE XR (saxagliptin and metformin); METAGLIP (glipizide and metformin); PrandiMet (metformin and repaglinide); XIGDUO XR (dapagliflozin and metformin) Glucagon-like peptide-1 (GLP-1) receptor agonists (albiglutide, dulaglutide, exenatide, liraglutide) Available as BYDUREON (extended-release exenatide); BYETTA (regular exenatide); TANZEUM (albiglutide); TRULICITY (dulaglutide); Victoza (liraglutide) Dipeptidyl peptidase-4 (DPP-4) inhibitors (alogliptin, linagliptin, saxagliptin, sitagliptin) Available as Januvia (sitagliptin); NESINA (alogliptin); Onglyza (saxagliptin); Tradjenta (linagliptin) Janumet, Janumet XR (metformin and sitagliptin); Jentadueto (linagliptin and metformin); Juvisync (sitagliptin and simvastatin); KAZANO (alogliptin and metformin); KOMBIGLYZE XR (saxagliptin and metformin); OSENI (alogliptin and pioglitazon) Insulins (aspart, detemir, glargine, glulisine, human, lispro) Available as Apidra (glulisine); Humalog, Humalog Mix50/50, Humalog Mix75/25 (lispro); Humulin N, Humulin R, Humulin 70/30 (human); Lantus (glargine); Levemir (detemir); Novolin N, Novolin R, Novolin 70/30 (human); NovoLog, NovoLog Mix 70/30 (aspart) Dopamine receptor agonist (bromocriptine mesylate) Available as CYCLOSET Inhaled Meglitinides (nateglinide, repaglinide) Available as Prandin (repaglinide); Starlix (nateglinide) PrandiMet (metformin and repaglinide) Insulin (human) Available as AFREZZA (insulin human) Sodium-glucose co-transporter 2 (SGLT2) inhibitors (canagliflozin, dapagliflozin, empagliflozin) Availble as FARXIGA (dapagliflozin), INVOKANA (canagliflozin), Jardiance (empagliflozin) XIGDUO XR (dapagliflozin and metformin) Sulfonylureas (glimepiride, glipizide, gliburidae) Available as Amaryl (glimepiride); DiaBeta, Glynase PresTab, or Micronase (gliburide); Glucotrol, Glucotrol XL (glipizide) Avandaryl (glimepiride and rosiglitazone); duetact (pioglitazone and glimepiride); GLUCOVANCE (gliburide and metformin); METAGLIP (glipizide and metformin) Thiazolidinediones (pioglitazone, rosiglitazone) Available as ACTOS (pioglitazone); Avandia (rosiglitazone) ACTOplus met, ACTOplus met XR (pioglitazone and metformin); Avandamet (rosiglitazone and metformin); Avandaryl (rosiglitazone and glimepiride); duetact (pioglitazone and glimepiride); OSENI (alogliptine and pioglitazone) This list of medications is provided for informational purposes only. Talk with your healthcare provider before starting or stopping any medications. The medications discussed are approved for use in the United States by the U.S. Food and Drug Administration (FDA) unless otherwise noted. Consult individual manufacturer s prescribing information for approved uses outside the United States. Updated December 2014 This content was created by KnowledgePoint360 Group, LLC, and was not associated with funding via an educational grant or a promotional/commercial interest.

6

7 Medicamentos para el tratamiento de la diabetes tipo 2 Medicamentos para el tratamiento de la diabetes tipo 2 A continuación se indican los nombres de los medicamentos disponibles para la diabetes tipo 2. Orales Inhibidores de la alfa-glucosidasa (acarbosa, miglitol) Ejemplos: Glyset (miglitol); PRECOSE (acarbosa) Biguanida (metformina) Ejemplos: Fortamet, GLUCOPHAGE, GLUCOPHAGE XR, Glumetza, Riomet (metformina) ACTOplus met, ACTOplus met XR (pioglitazona y metformina); Avandamet (rosiglitazona y metformina); GLUCOVANCE (gliburida y metformina); Janumet, Janumet XR (metformina y sitagliptina); Jentadueto (linagliptina y metformina); KAZANO (alogliptina y metformina); KOMBIGLYZE XR (saxagliptina y metformina); METAGLIP (glipizida y metformina); PrandiMet (metformina y repaglinida) Inhibidores de la dipeptidil peptidasa-4 (DPP-4) (alogliptina, linagliptina, saxagliptina, sitagliptina) Ejemplos: Januvia (sitagliptina); NESINA (alogliptina); Onglyza (saxagliptina); Tradjenta (linagliptina) Janumet, Janumet XR (metformina y sitagliptina); Jentadueto (linagliptina y metformina); Juvisync (sitagliptina y simvastatina); KAZANO (alogliptina y metformina); KOMBIGLYZE XR (saxagliptina y metformina); OSENI (alogliptina y pioglitazona) Meglitinidas (nateglinida, repaglinida) Ejemplos: Prandin (repaglinida); Starlix (nateglinida) Producto combinado: PrandiMet (metformina y repaglinida) Inhibidores del cotransportador sodio-glucosa 2 (SGLT2) (canagliflozina, dapagliflozina) Ejemplos: FARXIGA (dapagliflozina), INVOKANA (canagliflozina) Sulfonilureas (glimepirida, glipizida, gliburida) Ejemplos: Amaryl (glimepirida); DiaBeta, Glynase PresTab, o Micronase (gliburida); Glucotrol, Glucotrol XL (glipizida) Avandaryl (glimepirida y rosiglitazona); duetact (pioglitazona y glimepirida); GLUCOVANCE (gliburida y metformina); METAGLIP (glipizida y metformina) Tiazolidindionas (pioglitazona, rosiglitazona) Ejemplos: ACTOS (pioglitazona); Avandia (rosiglitazona) ACTOplus met, ACTOplus met XR (pioglitazona y metformina); Avandamet (rosiglitazona y metformina); Avandaryl (rosiglitazona y glimepirida); duetact (pioglitazona y glimepirida); OSENI (alogliptina y pioglitazona) Mimético de la amilina (pramlintida) Ejemplo: SYMLIN (pramlintida) Inyectables Agonistas del receptor del péptido 1 análogo al glucagón (GLP-1) (exenatida, liraglutida) Ejemplos: BYETTA (exenatida corriente); BYDUREON (exenatida de liberación prolongada); Victoza (liraglutida) Insulinas (aspártica, detemir, glargina, glulisina, humana, lispro) Ejemplos: Apidra (glulisina); Humalog, Humalog Mix50/50, Humalog Mix75/25 (lispro); Humulin N, Humulin R, Humulin 70/30 (humana); Lantus (glargina); Levemir (detemir); Novolin N, Novolin R, Novolin 70/30 (humana); NovoLog, NovoLog Mix 70/30 (aspártica) Esta lista de medicamentos se ofrece únicamente con fines informativos. Consulte con su profesional de la salud antes de iniciar o suspender cualquier tratamiento con medicamentos. Los medicamentos descritos están aprobados para su uso en los Estados Unidos por la Administración de Alimentos y Medicamentos (FDA) a menos que se indique lo contrario. Consulte la información de prescripción de cada fabricante para saber los usos aprobados en el exterior de los Estados Unidos. Julio de 2014 Patrocinado por KnowledgePoint360 Group, LLC, Lyndhurst, NJ. Copyright 2014 KnowledgePoint360 Group, LLC. Reservados todos los derechos. El contenido de esta hoja fue creado por KnowledgePoint360 Group, LLC, y no estuvo asociado a ningún financiamiento a través de una subvención educativa o un interés publicitario o comercial.

DIABETES EDUCATION. *Read package insert each time you refill your medications in case there is new information SULFONYLUREAS

DIABETES EDUCATION. *Read package insert each time you refill your medications in case there is new information SULFONYLUREAS DIABETES EDUCATION *Read package insert each time you refill your medications in case there is new information SULFONYLUREAS ACTION: Sulfonylureas stimulate the pancreas to make more insulin (pancreas

More information

Type 2 Diabetes Medicines: What You Need to Know

Type 2 Diabetes Medicines: What You Need to Know Type 2 Diabetes Medicines: What You Need to Know Managing diabetes is complex because many hormones and body processes are at work controlling blood sugar (glucose). Medicines for diabetes include oral

More information

Medicines Used to Treat Type 2 Diabetes

Medicines Used to Treat Type 2 Diabetes Goodman Diabetes Service Medicines Used to Treat Type 2 Diabetes People who have type 2 diabetes may need to take medicine to help lower their blood glucose, in addition to being active & choosing healthy

More information

Noninsulin Diabetes Medications Summary Chart Medications marked with an asterisk (*) can cause hypoglycemia MED GROUP DESCRIPTOR

Noninsulin Diabetes Medications Summary Chart Medications marked with an asterisk (*) can cause hypoglycemia MED GROUP DESCRIPTOR Noninsulin Diabetes Medications Summary Chart Medications marked with an asterisk (*) can cause MED GROUP DESCRIPTOR INSULIN SECRETAGOGUES Sulfonylureas* GLYBURIDE* (Diabeta) (Micronase) MICRONIZED GLYBURIDE*

More information

FYI: (Acceptable range for blood glucose usually 70-110 mg/dl. know your institutions policy.)

FYI: (Acceptable range for blood glucose usually 70-110 mg/dl. know your institutions policy.) How Insulin Works: Each type of insulin has an onset, a peak, and a duration time. Onset is the length of time before insulin reaches the bloodstream and begins lowering blood Peak is the time during which

More information

10/30/2012. Anita King, DNP, RN, FNP, CDE, FAADE Clinical Associate Professor University of South Alabama Mobile, Alabama

10/30/2012. Anita King, DNP, RN, FNP, CDE, FAADE Clinical Associate Professor University of South Alabama Mobile, Alabama Faculty Medications for Diabetes Satellite Conference and Live Webcast Wednesday, November 7, 2012 2:00 4:00 p.m. Central Time Anita King, DNP, RN, FNP, CDE, FAADE Clinical Associate Professor University

More information

Acarbose INITIAL: 25 mg PO TID ($45) Miglitol INITIAL: 25 mg PO TID ($145)

Acarbose INITIAL: 25 mg PO TID ($45) Miglitol INITIAL: 25 mg PO TID ($145) PL Detail-Document #310601 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER June 2015 Drugs for Type 2

More information

Targeting the Kidney. Renal Glucose Transport 11/4/2015. Non insulin Agents Available IBITORS. Chao EC, et al. Nat Rev Drug Discovery. 2010;9:551 559.

Targeting the Kidney. Renal Glucose Transport 11/4/2015. Non insulin Agents Available IBITORS. Chao EC, et al. Nat Rev Drug Discovery. 2010;9:551 559. SGLT-2i and DPP-IVi in the Management of Diabetes Mellitus Type 2 Abel Alfonso, D.O., F.A.C.E. Endocrinologist November 5, 2015 DIABETES: CURRENT RATES AND PROJECTIONS CDC Press Release 2010: 1 in 3 adults

More information

Medicines for Type 2 Diabetes A Review of the Research for Adults

Medicines for Type 2 Diabetes A Review of the Research for Adults Medicines for Type 2 Diabetes A Review of the Research for Adults Is This Information Right for Me? Yes, if: Your doctor or health care provider has told you that you have type 2 diabetes and have high

More information

How To Treat Diabetes

How To Treat Diabetes Overview of Diabetes Medications Marie Frazzitta DNP, FNP c, CDE, MBA Senior Director of Disease Management North Shore LIJ Health Systems Normal Glucose Metabolism Insulin is produced by beta cells in

More information

Approximate Cost Reference List i for Antihyperglycemic Agents

Approximate Cost Reference List i for Antihyperglycemic Agents Alpha Glucosidase Inhibitor Acarbose (Glucobay ) Biguanides Metformin (Glucophage, generic) Metformin ER (Glumetza ) Approximate Cost Reference List i for Antihyperglycemic Agents Incretin Agents - DPP-4

More information

Mary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes

Mary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes Mary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes Objectives Pathophysiology of Diabetes Acute & Chronic Complications Managing acute emergencies Case examples 11/24/2014 UWHealth

More information

What I need to know about. Diabetes Medicines. National Diabetes Information Clearinghouse

What I need to know about. Diabetes Medicines. National Diabetes Information Clearinghouse What I need to know about Diabetes Medicines National Diabetes Information Clearinghouse What I need to know about Diabetes Medicines Contents What do diabetes medicines do?... 1 What targets are recommended

More information

Diabetes Medications. Minal Patel, PharmD, BCPS

Diabetes Medications. Minal Patel, PharmD, BCPS Diabetes Medications Minal Patel, PharmD, BCPS Objectives Examine advantages and disadvantages of oral anti-hyperglycemic medications Describe the differences between different classes of insulin Explore

More information

Pharmaceutical Management of Diabetes Mellitus

Pharmaceutical Management of Diabetes Mellitus 1 Pharmaceutical Management of Diabetes Mellitus Diabetes Mellitus (cont d) Signs and symptoms 2 Elevated fasting blood glucose (higher than 126 mg/dl) or a hemoglobin A1C (A1C) level greater than or equal

More information

Diabetes Update Lanita S. Shaverd, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor, UAMS College of Pharmacy

Diabetes Update Lanita S. Shaverd, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor, UAMS College of Pharmacy Objectives Review oral medications used for the treatment of diabetes Explain how to effectively combine oral diabetes medications for optimal results Discuss insulins and non-insulin injectable diabetes

More information

Fundamentals of Diabetes Care Module 5, Lesson 1

Fundamentals of Diabetes Care Module 5, Lesson 1 Module 5, Lesson 1 Fundamentals of Diabetes Care Module 5: Taking Medications Healthy Eating Being Active Monitoring Taking Medication Problem Solving Healthy Coping Reducing Risks Foundations For Control

More information

Pills for Type 2 Diabetes. A Guide for Adults

Pills for Type 2 Diabetes. A Guide for Adults Pills for Type 2 Diabetes A Guide for Adults December 2007 Fast Facts on Diabetes Pills n Different kinds of diabetes pills work in different ways to control blood sugar (blood glucose). n All the diabetes

More information

Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians

Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians Clinician Research Summary Diabetes Type 2 Diabetes Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians A systematic review of 166 clinical studies published between

More information

Diabetes Mellitus Pharmacology Review

Diabetes Mellitus Pharmacology Review Diabetes Mellitus Pharmacology Review Hien T. Nguyen, Pharm.D., BCPS Clinical Pharmacist Specialist AtlantiCare Regional Medical Center E-Mail: HienT.Nguyen@atlanticare.org Objectives 1. Review the epidemiology

More information

Diabetes Treatments: Options for Insulin Delivery. Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute

Diabetes Treatments: Options for Insulin Delivery. Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute Diabetes Treatments: Options for Insulin Delivery Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute Diabetes 21 million people in the U.S. have diabetes $132 billion each

More information

Medications for Type 2 Diabetes

Medications for Type 2 Diabetes Main Page Risk Factors Symptoms Diagnosis Treatment Screening Complications Reducing Your Risk Talking to Your Doctor Living With Type 2 Diabetes Resource Guide Medications for Type 2 Diabetes by Karen

More information

we have to keep up. Timothy S. Reid, M.D. Mercy Diabetes Center Janesville, WI Entity Activity Financial Consideration Comments

we have to keep up. Timothy S. Reid, M.D. Mercy Diabetes Center Janesville, WI Entity Activity Financial Consideration Comments Timothy S. Reid, M.D. Mercy Diabetes Center Janesville, WI Entity Activity Financial Consideration Comments Novo Nordisk Speaker/Consultant Speaker Fees/Honoraria Sanofi-Aventis Speaker/Consultant Speaker

More information

Add: 2 nd generation sulfonylurea or glinide or Add DPP-4 inhibitor Start or intensify insulin therapy if HbA1c goals not achieved with the above

Add: 2 nd generation sulfonylurea or glinide or Add DPP-4 inhibitor Start or intensify insulin therapy if HbA1c goals not achieved with the above Guidelines for Type Diabetes - Diagnosis Fasting Plasma Glucose (confirm results if borderline) HbAIC Normal FPG < 00 < 5.5 Impaired Fasting Glucose (IFG) 00 to < 5.7%-.5% Diabetes Mellitus (or random

More information

Guidelines for Type 2 Diabetes Diagnosis

Guidelines for Type 2 Diabetes Diagnosis Guidelines for Type 2 Diabetes Diagnosis Fasting Plasma Glucose (in asymptomatic individuals, repeat measurement to confirm the test) Normal FPG < 100 2-hr OGTT < 140 HbA1C < 5.5% Impaired Fasting Glucose

More information

Diabetes: Medications

Diabetes: Medications Diabetes: Medications Presented by: APS Healthcare Southwestern PA Health Care Quality Unit (APS HCQU) May 2008 sh Disclaimer Information or education provided by the HCQU is not intended to replace medical

More information

Making Clinical Sense of Diabetes Medications. Types of Diabetes. Pathophysiology. Beta Cell Function & Glucagon

Making Clinical Sense of Diabetes Medications. Types of Diabetes. Pathophysiology. Beta Cell Function & Glucagon Making Clinical Sense of Diabetes Medications Kathy Reily, RD, CDE Prince William Hospital Diabetes Program Coordinator Virginia Dietetic Association April 4, 2011 Types of Diabetes Type 1 DM = Beta Cell

More information

TREATMENT STRATEGIES FOR MANAGING TYPE 2 DIABETES MELLITUS. Friday, August 16, 13

TREATMENT STRATEGIES FOR MANAGING TYPE 2 DIABETES MELLITUS. Friday, August 16, 13 TREATMENT STRATEGIES FOR MANAGING TYPE 2 DIABETES MELLITUS 1 Heather Healy, FNP-BC Martha Shelver, CS, ACNP-BC Saint Alphonsus Regional Medical Center 2 OBJECTIVES 3 Review the current management algorithms

More information

Class Update: Diabetes Medications. Month/Year of Review: September 2014 End date of literature search: August 2014

Class Update: Diabetes Medications. Month/Year of Review: September 2014 End date of literature search: August 2014 Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Volume 01, No. 08 November 2013

Volume 01, No. 08 November 2013 State of New Jersey Department of Human Services Division of Medical Assistance & Health Services New Jersey Drug Utilization Review Board Volume 01, No. 08 November 2013 TO: SUBJECT: PURPOSE: Physicians,

More information

My Diabetes Care Plan

My Diabetes Care Plan My Diabetes Care Plan You may use the charts below to help you better understand your diabetes. Ask your healthcare provider to review your goals and targets with you. Discuss the results and set up an

More information

Oral Therapy for Type 2 Diabetes

Oral Therapy for Type 2 Diabetes Oral Therapy for Type 2 Diabetes Diabetes pills can help to manage your blood sugar. These pills are not insulin. They work to manage your blood sugar in several ways. You may be given a combination of

More information

Antidiabetic Drugs. Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.

Antidiabetic Drugs. Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Antidiabetic Drugs Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Diabetes Mellitus Two types Type 1 Type 2 Type 1 Diabetes Mellitus Lack of insulin production

More information

Type 2 Diabetes Update For 2015

Type 2 Diabetes Update For 2015 Type 2 Diabetes Update For 2015 Jerry Meece, RPh, CDE, FACA, FAADE Plaza Pharmacy and Wellness Center jmeece12@cooke.net Learning Objectives At the conclusion of this presentation, the participant will

More information

Anti-Diabetic Agents. Chapter. Charles Ruchalski, PharmD, BCPS. Drug Class: Biguanides. Introduction. Metformin

Anti-Diabetic Agents. Chapter. Charles Ruchalski, PharmD, BCPS. Drug Class: Biguanides. Introduction. Metformin Chapter Anti-Diabetic Agents 2 Charles Ruchalski, PharmD, BCPS Drug Class: Biguanides The biguanide metformin is the drug of choice as initial therapy for a newly diagnosed patient with type 2 diabetes

More information

It is estimated that 25.8 million people or 8.3% of the US

It is estimated that 25.8 million people or 8.3% of the US 1.0 CPEUs and 2.0 ANCC Contact Hours An Overview of Glycemic Goals and Medications Used to Manage Type 2 Diabetes Mary-Kathleen Grams, PharmD Suzanne Dinsmore, PharmD, CGP Jennifer Goldman-Levine, PharmD,

More information

Cara Liday, PharmD, CDE Associate Professor, Idaho State University Clinical Pharmacist and CDE, InterMountain Medical Center Pocatello, ID The planners and presenter have disclosed no conflict of interest,

More information

4/23/2015. Conflict of Interest Disclosure

4/23/2015. Conflict of Interest Disclosure Endocrine/Diabetes Pharmacology Review May 8, 2015 Chris Winslow, PharmD, MBA and Amanda Brown, PharmD Conflict of Interest Disclosure A conflict of interest exists when an individual is in a position

More information

Diabetes Fundamentals

Diabetes Fundamentals Diabetes Fundamentals Prevalence of Diabetes in the U.S. Undiagnosed 10.7% of all people 20+ 23.1% of all people 60+ (12.2 million) Slide provided by Roche Diagnostics Sources: ADA, WHO statistics Prevalence

More information

New and Emerging Diabetes Medications. What do Advanced Practice Nurses Need to Know? Lorraine Nowakowski-Grier,MSN,APRN,BC,CDE

New and Emerging Diabetes Medications. What do Advanced Practice Nurses Need to Know? Lorraine Nowakowski-Grier,MSN,APRN,BC,CDE New and Emerging Diabetes Medications What do Advanced Practice Nurses Need to Know? Lorraine Nowakowski-Grier,MSN,APRN,BC,CDE Objectives 1) Describe the clinical indications on select emerging novel diabetes

More information

DIABETES MEDICATION-ORAL AGENTS AND OTHER HYPOGLYCEMIC AGENTS

DIABETES MEDICATION-ORAL AGENTS AND OTHER HYPOGLYCEMIC AGENTS Section Two DIABETES MEDICATION-ORAL AGENTS AND OTHER HYPOGLYCEMIC AGENTS This section will: Describe oral agents (pills) are specific for treating type 2 diabetes. Describe other hypoglycemic agents used

More information

Medications for Diabetes

Medications for Diabetes AGS Diab Med Brochure 4/18/03 3:43 PM Page 1 Medications for Diabetes An Older Adult s Guide to Safe Use of Diabetes Medications THE AGS FOUNDATION FOR HEALTH IN AGING AGS Diab Med Brochure 4/18/03 3:43

More information

6/22/2015. New medicines for type 2 diabetes when do you use them

6/22/2015. New medicines for type 2 diabetes when do you use them New medicines for type 2 diabetes when do you use them 1. Oral Secretagogues (e.g. sulfonylureas) 2. Metformin 3. Alpha glucosidase inhibitors 4. Thiazolidinediones 5. GLP-1 receptor agonists 6. DPP-4

More information

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets Read this Medication Guide carefully before you start taking KOMBIGLYZE XR and each time you get

More information

Let s Talk About Meters and Meds. Adapted for Upstate Medical University by: Kristi Shaver, BS, RN, CDE, MS-CNS Student (2014) January 2014

Let s Talk About Meters and Meds. Adapted for Upstate Medical University by: Kristi Shaver, BS, RN, CDE, MS-CNS Student (2014) January 2014 Let s Talk About Meters and Meds Adapted for Upstate Medical University by: Kristi Shaver, BS, RN, CDE, MS-CNS Student (2014) January 2014 How to monitor diabetes control: Hemoglobin A 1 C, or just A 1

More information

The prevalence of diabetes in the United States in

The prevalence of diabetes in the United States in Medical Management of Type 2 Diabetes Celia Levesque, CNS-BC ABSTRACT More than 20 million Americans have type 2 diabetes. Managing blood glucose is an important component in delaying, slowing, or preventing

More information

Chapter 4 Type 2 Diabetes

Chapter 4 Type 2 Diabetes Chapter 4 Type 2 Diabetes (previously referred to as adult onset diabetes or non-insulin dependent diabetes) H. Peter Chase, MD Cindy Cain, RN, CDE Philip Zeitler, MD This is the most common type of diabetes

More information

Transitions: MNT for Basic Diabetes Medications to Complex Insulin Regimens. Sara Weigel RDN, LD, CDE MAND Annual Meeting May 1 st 2015

Transitions: MNT for Basic Diabetes Medications to Complex Insulin Regimens. Sara Weigel RDN, LD, CDE MAND Annual Meeting May 1 st 2015 Transitions: MNT for Basic Diabetes Medications to Complex Insulin Regimens Sara Weigel RDN, LD, CDE MAND Annual Meeting May 1 st 2015 Objectives 1) Describe and discuss some of the most common diabetes

More information

25 mg QD-TID @ meals w/1st bite of. food, titrate Q 4 8 weeks; adjust based on 1 postprandial glucose; 100 mg TID max

25 mg QD-TID @ meals w/1st bite of. food, titrate Q 4 8 weeks; adjust based on 1 postprandial glucose; 100 mg TID max Table Selected Non-Insulin Antihyperglycemic Agents Class Drug (Brand) Dosing Comments -Glucosidase inhibitors Acarbose a (Precose) 25 mg QD-TID @ meals w/1st bite of MOA: Enzyme inhibitor, delays hydrolysis

More information

Diabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur?

Diabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur? What is type 2 diabetes? Type 2 diabetes is a disorder that happens when your body does not make enough insulin or is unable to use its own insulin properly. The inability to use insulin is called insulin

More information

Antidiabetic Agents. Chapter. Biguanides

Antidiabetic Agents. Chapter. Biguanides ajt/shutterstock, Inc. Chapter 2 Antidiabetic Agents Charles Ruchalski, PharmD, BCPS Biguanides Introduction For newly diagnosed patients with type 2 diabetes, the biguanide metformin is the drug of choice

More information

Drug Class Review. Newer Diabetes Medications and Combinations

Drug Class Review. Newer Diabetes Medications and Combinations Drug Class Review Newer Diabetes Medications and Combinations Final Streamlined Update 1 Report June 2014 The purpose of Drug Effectiveness Review Project reports is to make available information regarding

More information

Treatment of Type 2 Diabetes

Treatment of Type 2 Diabetes Improving Patient Care through Evidence Treatment of Type 2 Diabetes This information is based on a comprehensive review of the evidence for best practices in the treatment of type 2 diabetes and is sponsored

More information

Primary Care Type 2 Diabetes Update

Primary Care Type 2 Diabetes Update Primary Care Type 2 Diabetes Update May 16, 2014 Presented by: Barb Risnes APRN, BC-ADM, CDE Objectives: Discuss strategies to address common type 2 diabetes patient management challenges Review new pharmacological

More information

Treating Type 2 Diabetes

Treating Type 2 Diabetes The Oral Diabetes Drugs Treating Type 2 Diabetes Comparing Effectiveness, Safety, and Price Contents Our Recommendations........................................... 3 Welcome....................................................

More information

2013 International Diabetes Center

2013 International Diabetes Center Day to Day Management of Diabetes Part 1 Review of Diabetes and Therapies Diane Reader RD, CDE Manager, Diabetes Professional Training International Diabetes Center Overview of Diabetes lucose and Insulin

More information

Treating Type 2 Diabetes

Treating Type 2 Diabetes The Oral Diabetes Drugs Treating Type 2 Diabetes Comparing Effectiveness, Safety, and Price Our Recommendations Six classes of oral medicines (and 12 individual drugs) are now available to help the 25.8

More information

Staying Healthy With Diabetes

Staying Healthy With Diabetes Staying Healthy With Diabetes For: We care. We will listen. We can help. Table of Contents Table of Contents... 1 Staying Healthy with Diabetes... 2 About Diabetes... 3 Blood Glucose Testing at Home...

More information

Update on the management of Type 2 Diabetes

Update on the management of Type 2 Diabetes Update on the management of Type 2 Diabetes Mona Nasrallah M.D Assistant Professor, Endocrinology American University of Beirut 10 th Annual Family Medicine Conference October 14,2011 Global Prevalence

More information

Clinical Assistant Professor. Clinical Pharmacy Specialist Wesley Family Medicine Residency Program. Objectives

Clinical Assistant Professor. Clinical Pharmacy Specialist Wesley Family Medicine Residency Program. Objectives What s New in Diabetes Medications? Matthew Kostoff, PharmD, BCPS, BCACP Clinical Assistant Professor Clinical Pharmacy Specialist Wesley Family Medicine Residency Program Objectives Discuss new literature

More information

Antihyperglycemic Agents Comparison Chart

Antihyperglycemic Agents Comparison Chart Parameter Metformin Sulfonylureas Meglitinides Glitazones (TZD s) Mechanism of Action Efficacy (A1c Reduction) Hepatic glucose output Peripheral glucose uptake by enhancing insulin action insulin secretion

More information

Libyan International Medical University www.limu.edu.ly PBL-III. ZuhirBodalal

Libyan International Medical University www.limu.edu.ly PBL-III. ZuhirBodalal Libyan International Medical University www.limu.edu.ly PBL-III ZuhirBodalal Disclaimer The following is a collection of medical information from multiple sources, both online and offline. It is to be

More information

medications for type 2 diabetes

medications for type 2 diabetes Talking diabetes No.25 Revised August 2010 medications for type 2 diabetes People with type 2 diabetes are often given medications including insulin to help control their blood glucose levels. Most of

More information

medications for type 2 diabetes

medications for type 2 diabetes Talking diabetes No.25 Revised 2012 medications for type 2 diabetes People with type 2 diabetes are often given medications including insulin to help manage their blood glucose levels. Most of these medications

More information

My Diabetes Care Plan

My Diabetes Care Plan My Diabetes Care Plan You may use the charts below to help you better understand your diabetes. Ask your healthcare provider to review your goals and targets with you. Discuss the results and set up an

More information

Harmony Clinical Trial Medical Media Factsheet

Harmony Clinical Trial Medical Media Factsheet Overview Harmony is the global Phase III clinical trial program for Tanzeum (albiglutide), a product developed by GSK for the treatment of type 2 diabetes. The comprehensive program comprised eight individual

More information

Diabetes Medications at the End of Life. Goals and Objectives. Diabetes. Type 2 Diabetes Mellitus. Types of Diabetes

Diabetes Medications at the End of Life. Goals and Objectives. Diabetes. Type 2 Diabetes Mellitus. Types of Diabetes Diabetes Medications at the End of Life Paul J. Schmidt Jr., R.Ph., M.S. Clinical Supervisor HospiScript Services pschmidt@hospiscript.com Goals and Objectives Describe the Current Impact of Diabetes Mellitus

More information

UVA OUTPATIENT SURGERY CENTER (OPSC) PREPARING FOR SURGERY HANDBOOK

UVA OUTPATIENT SURGERY CENTER (OPSC) PREPARING FOR SURGERY HANDBOOK Surgeon Name/PIC: Surgery Name: Surgery Date: Patient Label or Patient NAME Patient UVA MRN ARRIVAL TIME: (provided by OPSC nurse during phone call) UVA OUTPATIENT SURGERY CENTER (OPSC) PREPARING FOR SURGERY

More information

Treating Type 2 Diabetes: The Oral Diabetes Drugs. Comparing Effectiveness, Safety, and Price

Treating Type 2 Diabetes: The Oral Diabetes Drugs. Comparing Effectiveness, Safety, and Price Treating Type 2 Diabetes: The Oral Diabetes Drugs Comparing Effectiveness, Safety, and Price Our Recommendations Six types of oral medicines (and 11 individual drugs) are now available to help the 21 million

More information

New Non-Insulin Therapies for Type 2 Diabetes Mellitus

New Non-Insulin Therapies for Type 2 Diabetes Mellitus New Non-Insulin Therapies for Type 2 Diabetes Mellitus Ally P.H. Prebtani Associate Professor of Medicine Internal Medicine, Endocrinology & Metabolism McMaster University Canada Disclosure Relationships

More information

How To Help People With Diabetes

How To Help People With Diabetes Diabetes Medications and Medication Management Christopher Lamer, PharmD, MHS, BCPS, CDE November 2013 Okay, great. Well, I want to say thank you very much for giving me the opportunity to present and

More information

Type 2 diabetes Definition

Type 2 diabetes Definition Type 2 diabetes Definition Type 2 diabetes is a lifelong (chronic) disease in which there are high levels of sugar (glucose) in the blood. Type 2 diabetes is the most common form of diabetes. Causes Diabetes

More information

Hypoglycemia. National Diabetes Information Clearinghouse

Hypoglycemia. National Diabetes Information Clearinghouse Hypoglycemia National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is hypoglycemia? Hypoglycemia, also called low blood glucose or

More information

Diabetes: Beyond the D50. Leslie Huntington, BS, Paramedic Mobile Training Unit Oregon OHA-EMS and Trauma Systems

Diabetes: Beyond the D50. Leslie Huntington, BS, Paramedic Mobile Training Unit Oregon OHA-EMS and Trauma Systems Diabetes: Beyond the D50 Leslie Huntington, BS, Paramedic Mobile Training Unit Oregon OHA-EMS and Trauma Systems The EMS View of Diabetes Management BG low? Give some form of sugar. Hero! BG somewhere

More information

Controversies in the Management of Patients with Type 2 Diabetes

Controversies in the Management of Patients with Type 2 Diabetes The New England Comparative Effectiveness Public Advisory Council Public Meeting October 29, 2014 Controversies in the Management of Patients with Type 2 Diabetes Draft Report September 2014 Authored by:

More information

SUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS

SUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS SUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS PURPOSE To establish a process that will enable Certified Diabetes Educators (CDE) and/or staff with Board Certification in Advanced Diabetes Management

More information

E-mail: david.bruyette@vcahospitals.com www.veterinarydiagnosticinvestigation.com

E-mail: david.bruyette@vcahospitals.com www.veterinarydiagnosticinvestigation.com David Bruyette, DVM, DACVIM VCA West Los Angeles Animal Hospital 1818 South Sepulveda Blvd Los Angeles, CA 90025 310-473-2951 (ext 226) E-mail: david.bruyette@vcahospitals.com www.veterinarydiagnosticinvestigation.com

More information

Diabetes WHAT YOU NEED TO KNOW. What is Diabetes? Inside:

Diabetes WHAT YOU NEED TO KNOW. What is Diabetes? Inside: Diabetes WHAT YOU NEED TO KNOW What is Diabetes? Diabetes means that there is too much sugar in your blood. Too much sugar causes damage to the body. Diabetes happens when there is a problem with a hormone

More information

Diabetes Mellitus Type 2

Diabetes Mellitus Type 2 Diabetes Mellitus Type 2 What is it? Diabetes is a common health problem in the U.S. and the world. In diabetes, the body does not use the food it digests well. It is hard for the body to use carbohydrates

More information

Diana G. Mercurio, RPh, CDE, CDOE, CVDOE October 9, 2015

Diana G. Mercurio, RPh, CDE, CDOE, CVDOE October 9, 2015 Diana G. Mercurio, RPh, CDE, CDOE, CVDOE October 9, 2015 I do not have any significant financial relationships to disclose. Primary prevention: treatment of individuals with no history of stroke Secondary

More information

Premixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s

Premixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s Premixed Insulin for Type 2 Diabetes a gu i d e f o r a d u lt s March 2009 What This Guide Covers / 2 Type 2 Diabetes / 3 Learning About Blood Sugar / 4 Learning About Insulin / 5 Comparing Medicines

More information

OBJECTIVES MEDICATIONS TO TREAT DIABETES MELLITUS. History of Diabetes Care. Barriers To Normalizing BG 2/11/2014. Significant Developments in DM

OBJECTIVES MEDICATIONS TO TREAT DIABETES MELLITUS. History of Diabetes Care. Barriers To Normalizing BG 2/11/2014. Significant Developments in DM MEDICATIONS TO TREAT DIABETES MELLITUS R. Keith Campbell*, RPh, FAADE, FASHP, CDE Distinguished Professor of Diabetes Care/Pharmacotherapy, Emeritus Washington State University College of Pharmacy *No

More information

Type 2 Diabetes. Aims and Objectives. What did you consider? Case Study One: Miss S. Which to choose?!?! Modes of Action

Type 2 Diabetes. Aims and Objectives. What did you consider? Case Study One: Miss S. Which to choose?!?! Modes of Action Aims and Objectives This session will outline the increasing complexities of diabetes care, and the factors that differentiate the combinations of therapy, allowing individualisation of diabetes treatment.

More information

Information for Patients

Information for Patients Information for Patients Guidance for Diabetic Persons having bowel preparation for a flexible sigmoidoscopy or a colonoscopy or a combined gastroscopy and colonoscopy This guidance is provided to assist

More information

Drug Class Review Newer Diabetes Medications, TZDs, and Combinations

Drug Class Review Newer Diabetes Medications, TZDs, and Combinations Drug Class Review Newer Diabetes Medications, TZDs, and Combinations Preliminary Scan Report #1 Update #1 February 2013 The purpose of reports is to make available information regarding the comparative

More information

Management of Clients with Diabetes Mellitus

Management of Clients with Diabetes Mellitus Management of Clients with Diabetes Mellitus Black, J.M. & Hawks, J.H. (2005) Chapters 47, (pp 1243-1288) 1288) Baptist Health School of Nursing NSG 4037: Adult Nursing III Carole Mackey, MNSc,, RN, PNP

More information

Endocrine Disorders. Diabetes Meds Objectives. Diabetes Type 1 and Type 2. Insulin Dynamics. Insulin is all about timing! Rapid acting insulin O P D

Endocrine Disorders. Diabetes Meds Objectives. Diabetes Type 1 and Type 2. Insulin Dynamics. Insulin is all about timing! Rapid acting insulin O P D Endocrine Disorders Diabetes Meds Objectives Explain the action of the various types of insulin currently available Identify the relationship between insulin peak and risk for hypoglycemia Discuss rationale

More information

Saxagliptin (Onglyza) for type 2 diabetes

Saxagliptin (Onglyza) for type 2 diabetes Saxagliptin (Onglyza) for type 2 diabetes This Medicine Update is for people who are taking, or thinking about taking, saxagliptin. Summary Saxagliptin (brand name Onglyza) is a tablet that can be used

More information

Prescribing for Diabetes. England 2005-06 to 2013-14

Prescribing for Diabetes. England 2005-06 to 2013-14 Prescribing for Diabetes England 2005-06 to 2013-14 Published 12 August 2014 We are the trusted national provider of high-quality information, data and IT systems for health and social care. www.hscic.gov.uk

More information

Management of Type 2 Diabetes Mellitus

Management of Type 2 Diabetes Mellitus Diabetes Mellitus Guideline Team Team Leaders Connie J Standiford, MD General Internal Medicine Sandeep Vijan, MD General Internal Medicine Team Members Hae Mi Choe, PharmD College of Pharmacy R Van Harrison,

More information

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES MEDICAL ASSISTANCE HBOOK I. Requirements for Prior Authorization of Incretin Mimetic/Enhancer Hypoglycemics (formerly referred to as Other Hypoglycemics) A. Thresholds for Prior Authorization All prescriptions

More information

Second- and Third-Line Approaches for Type 2 Diabetes Workgroup: Topic Brief

Second- and Third-Line Approaches for Type 2 Diabetes Workgroup: Topic Brief Second- and Third-Line Approaches for Type 2 Diabetes Workgroup: Topic Brief March 7, 2016 Session Objective: The objective of this workshop is to assess the value of undertaking comparative effectiveness

More information

Up to Date for Diabetes: Veronica Piziak MD, PhD Professor of Medicine Texas A&M Emeritus Director of Endocrinology Baylor Scott and White

Up to Date for Diabetes: Veronica Piziak MD, PhD Professor of Medicine Texas A&M Emeritus Director of Endocrinology Baylor Scott and White Up to Date for Diabetes: Veronica Piziak MD, PhD Professor of Medicine Texas A&M Emeritus Director of Endocrinology Baylor Scott and White Objectives: What is New in Therapy How to select medications Disclosures:

More information

Effective pharmacological treatment regimens for diabetes usually require

Effective pharmacological treatment regimens for diabetes usually require Medications Used in Diabetes in Patients Presenting for Anesthesia By Gabrielle O Connor, M.D., M.Sc., CCD, MRCP, FACP Dr. Gabrielle O Connor, a board certified endocrinologist who graduated from University

More information

MANAGEMENT OF TYPE 2 DIABETES: REVIEW OF DRUG THERAPY

MANAGEMENT OF TYPE 2 DIABETES: REVIEW OF DRUG THERAPY MANAGEMENT OF TYPE 2 DIABETES: REVIEW OF DRUG THERAPY AND THE ROLE OF THE PHARMACIST NINA BEMBEN, PHARMD MARY LYNN MCPHERSON, PAHRMD, MA, BCPS, CDE ZEMEN HABTEMARIAM, STUDENT PHARMACIST MANAGEMENT OF TYPE

More information

ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH.

ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH. ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH. ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO

More information

Prescribing for Diabetes, England 2005-06 to 2012-13

Prescribing for Diabetes, England 2005-06 to 2012-13 Prescribing for Diabetes, England 2005-06 to 2012-13 Published 13 August 2013 This product is relevant to members of the public and other stakeholders to support the understanding of primary care prescribing

More information

Diabetes may be classified as. i) Type - I Diabetes mellitus. Type - II Diabetes mellitus. Type - 1.5 Diabetes mellitus. Gestational Diabetes INSULIN

Diabetes may be classified as. i) Type - I Diabetes mellitus. Type - II Diabetes mellitus. Type - 1.5 Diabetes mellitus. Gestational Diabetes INSULIN HYPOGLYCEMIC AGENT Diabetes mellitus is a chronic metabolic disorder of multiple aetiology characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting

More information

JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets

JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets What is in this leaflet This leaflet answers some common questions about JANUVIA. It does not contain all the available information. It does

More information

Can one pill a day help lower your blood sugar?

Can one pill a day help lower your blood sugar? See inside for valuable savings offer Can one pill a day help lower your blood sugar? What is FARXIGA? FARXIGA is a prescription medicine used along with diet and exercise to lower blood sugar in adults

More information